向瘤微环境中频繁发生的血细胞分裂是癌症治疗的新方向
Gangxing Zhu1, Xinliang Wan1, Wanyin Wu1
1Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC Department of Oncology Guangdong Provincial Hospital of Chinese Medicine Chinese Medicine Guangdong Laboratory State Key Laboratory of Traditional Chinese Medicine Syndrome Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome State Key Laboratory of Dampness Syndrome of Chinese Medicine The Second Clinical College of Guangzhou University of Chinese Medicine Guangzhou 510120 Guangdong China.
准细胞衰变,即清除亡细胞的过程,提供了一种新的癌症治疗策略. 抑制过度的乙细胞增生可以增强抗瘤免疫力,克服治疗耐药性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 癌症的发展受到饮食,环境和遗传学的影响.
- 化疗和放射治疗面临着药物耐药性和副作用等挑战.
- 在传统治疗后,瘤微环境 (TME) 中的亡细胞增加.
研究的目的:
- 为了审查癌症中雌激细胞形成的分子机制.
- 概述目前针对癌症治疗的治疗策略.
- 突出抑制细胞酶以提高抗瘤免疫力的潜力.
主要方法:
- 审查现有的文学关于efferocytosis和癌症治疗.
- 分析涉及到epherocytosis的分子通路.
- 临床试验的总结,涉及细胞抑制剂.
主要成果:
- 过度的细胞增生可以产生免疫抑制的TME,阻碍瘤治疗.
- 抑制乙细胞酶促进免疫支持的TME,提高治疗疗效.
- 小分子抑制剂和单克隆抗体,以向细胞增生为目标,正在临床研究中.
结论:
- 向乙细胞形成为癌症治疗提供了一个有前途的新途径.
- 调节细胞酶可以克服对现有疗法的耐药性.
- 对效细胞酶机制的进一步研究将推动新型癌症药物的开发.
相关概念视频
The Tumor Microenvironment
Tumor Immunotherapy
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...


